Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides specialty pharmacy services and mail services. As of August 31, 2020, this segment operated 9,021 retail stores under the Walgreens and Duane Reade brands in the United States; and six specialty pharmacies. The Retail Pharmacy International segment sells prescription drugs; and health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty stores and optical practices, as well as through boots.com and an integrated mobile application. This segment operated 4,428 retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile; and 550 optical practices, including 165 on a franchise basis. The Pharmaceutical Wholesale segment engages in the wholesale and distribution of specialty and generic pharmaceuticals, health and beauty products, and home healthcare supplies and equipment, as well as provides related services to pharmacies and other healthcare providers. This segment operates in the United Kingdom, Germany, France, Turkey, Spain, the Netherlands, Egypt, Norway, Romania, the Czech Republic, and Lithuania. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.
IPO Year:
Exchange: NASDAQ
Website: walgreensbootsalliance.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 2/26/2024 | $23.00 | Market Perform | Leerink Partners |
| 2/20/2024 | Hold → Reduce | HSBC Securities | |
| 1/3/2024 | $21.00 | Underweight | Barclays |
| 12/22/2023 | $27.00 | Hold | HSBC Securities |
| 10/23/2023 | $27.00 → $30.00 | Neutral → Overweight | JP Morgan |
| 7/3/2023 | $37.00 → $27.00 | Underweight | Morgan Stanley |
| 6/28/2023 | $46.00 → $34.00 | Buy → Hold | Deutsche Bank |
| 2/23/2023 | $45.00 | Buy | Loop Capital |
| 11/23/2022 | $39.00 | Underweight | Morgan Stanley |
| 11/22/2022 | $43.00 → $54.00 | Market Perform → Outperform | Cowen |
For Immediate Release: September 12, 2023 The U.S. Food and Drug Administration has issued warning letters to eight companies for manufacturing or marketing unapproved ophthalmic drug products in violation of federal law. These warning letters are part of the agency’s ongoing effort to protect Americans from potentially harmful ophthalmic products. Eye products addressed in the eight warning letters are illegal
4 - Walgreens Boots Alliance, Inc. (0001618921) (Issuer)
4 - Walgreens Boots Alliance, Inc. (0001618921) (Issuer)
4 - Walgreens Boots Alliance, Inc. (0001618921) (Issuer)
4 - Walgreens Boots Alliance, Inc. (0001618921) (Issuer)
3 - Walgreens Boots Alliance, Inc. (0001618921) (Issuer)
4 - Walgreens Boots Alliance, Inc. (0001618921) (Reporting)
4 - Walgreens Boots Alliance, Inc. (0001618921) (Issuer)
4 - Walgreens Boots Alliance, Inc. (0001618921) (Issuer)
4 - Walgreens Boots Alliance, Inc. (0001618921) (Issuer)
4 - Walgreens Boots Alliance, Inc. (0001618921) (Issuer)
4 - Walgreens Boots Alliance, Inc. (0001618921) (Issuer)
4 - Walgreens Boots Alliance, Inc. (0001618921) (Issuer)
4 - Walgreens Boots Alliance, Inc. (0001618921) (Reporting)
4 - Walgreens Boots Alliance, Inc. (0001618921) (Issuer)
Company will close nearly all of its stores and pharmacies for the second consecutive year to give team members time with their loved ones; 24-Hour locations will remain open to meet customer and patient healthcare needs All Walgreens locations will be open on Christmas Day and New Year's Day On Thanksgiving Day (November 28), most Walgreens locations will be closed, except for 500 Walgreens 24-hour locations, and 300 pharmacies within those locations, that will remain open on Thanksgiving to help meet the healthcare needs of our customers. This is the second year in a row Walgreens has chosen to close its doors on Thanksgiving to allow team members to spend more time with loved ones. Thi
MOUNT PROSPECT, Ill., Sept. 10, 2024 /PRNewswire/ -- Walgreens has joined Pulse by NABP™, the new digital platform from National Association of Boards of Pharmacy® (NABP®) that will bring visibility to the drug supply chain and protect patients from counterfeit or substandard prescription medications. Walgreens will use Pulse to assist with Drug Supply Chain Security Act (DSCSA) compliance and to help ensure its prescription medication suppliers are appropriately licensed. Walgreens will use Pulse to assist with DSCSA compliance and protect patients from counterfeit prescripti
Walgreens Boots Alliance, Inc. (NASDAQ:WBA) will release its fourth quarter and 2024 fiscal year-end results at 7 a.m. ET on Tuesday, October 15, 2024, followed by a one-hour conference call with WBA management beginning at 8:30 a.m. ET. The conference call will be simulcast through the WBA investor relations website at: http://investor.walgreensbootsalliance.com. A replay will be archived on the website for 12 months after the call. About Walgreens Boots Alliance Walgreens Boots Alliance (NASDAQ:WBA) is an integrated healthcare, pharmacy and retail leader serving millions of customers and patients every day, with a 170-year heritage of caring for communities. A trusted, global innovato
Walgreens, the leading independent retail pharmacy and healthcare provider, today announced the launch of its new premium skin care line, designed to give customers premium quality without the premium price tag. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240905194546/en/Walgreens launches new line of premium skin care items. (Photo: Business Wire) In response to growing consumer demand for premium skin care solutions, Walgreens is redefining its beauty landscape and providing an efficient, highly relevant customer experience with a range of products that promise top-tier quality and affordability. Extensive research shows th
Walgreens today announced that Ramita Tandon, Chief Clinical Trials Officer, will deliver a keynote presentation at TD Cowen's 9th Annual FutureHealth Conference, Tuesday, Sept. 10 at 4:10 p.m. EST. An audio portion of the presentation will be webcast live and can be accessed through the Walgreens Boots Alliance investor relations website at https://investor.walgreensbootsalliance.com/press-releases/events-and-presentations. About Walgreens Walgreens (www.walgreens.com) is included in the U.S. Retail Pharmacy and U.S. Healthcare segments of Walgreens Boots Alliance, Inc. (NASDAQ:WBA), an integrated healthcare, pharmacy and retail leader. True to its purpose of "more joyful lives through
Collaboration Brings Innovative Neighborhood Pharmacy Benefits to Communities Nationwide, Helping Americans Save on Healthcare Costs Bilt Rewards, the pioneering loyalty program that transformed rent payments into rewards, today announced a significant expansion of its neighborhood rewards program through a strategic collaboration with Walgreens, the leading independent retail pharmacy and healthcare provider. This cooperative effort introduces an innovative "Automatic Healthcare Savings" program, marking the first time customers can effortlessly apply any network branded Flexible Spending Account (FSA) or Health Savings Account (HSA) benefits card to purchases at a major pharmacy chain.
This first-of-its-kind collaboration between Walgreens and U.S. government aims to address barriers in decentralized clinical trial access and conduct trials over a five-year period, valued up to $100 million for the D-COHRe program Walgreens and the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) in the U.S. Department of Health and Human Services (HHS), today announced a strategic partnership to increase innovation in decentralized clinical trials as part of the Decentralized Clinical Operations for Healthcare and Research (D-COHRe) program. The program is designed to strengthen U.S. decentralized
Names Tracey Koller as Chief Merchandising Officer and Sharmila Sudhakar as Group Vice President and Head of Digital Commerce Walgreens, the leading independent retail pharmacy and healthcare provider, today announced two key leadership appointments: Tracey Koller, senior vice president and chief merchandising officer, and Sharmila Sudhakar, group vice president and head of Walgreens digital commerce. The company believes these new appointments will significantly contribute to its efforts with regard to the turnaround of the business as the company focuses on enhancing the front of store and omnichannel experience for its customers while driving in-store efficiencies. This press release
Walgreens Boots Alliance, Inc. (NASDAQ:WBA) today announced the pricing of an underwritten public offering of senior unsecured notes consisting of $750,000,000 aggregate principal amount of 8.125% notes due 2029. The sale of the notes is expected to close on August 12, 2024, subject to customary closing conditions. WBA intends to use the net proceeds from the offering, together with cash on hand, for the repayment and/or retirement of its outstanding 3.800% notes due 2024, and to use any remaining amounts for general corporate purposes. The joint book-running managers for the offering are: J.P. Morgan Securities LLC, Wells Fargo Securities, LLC and BofA Securities, Inc. This press rel
Walgreens and Instacart now accept SNAP/EBT payments nationwide at more than 7,500 Walgreens stores Walgreens, the leading integrated independent retail pharmacy and healthcare provider, today announced a new collaboration with Instacart, the leading grocery technology company in North America, to offer online SNAP/EBT payment acceptance at more than 7,500 Walgreens stores nationwide, including over 100 Duane Reade locations in New York. Customers can now purchase thousands of SNAP-eligible products for same-day delivery via Instacart. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240806410409/en/Walgreens and Instacart now a
SC 13D/A - Walgreens Boots Alliance, Inc. (0001618921) (Filed by)
SC 13G/A - Walgreens Boots Alliance, Inc. (0001618921) (Subject)
SC 13D/A - Walgreens Boots Alliance, Inc. (0001618921) (Filed by)
SC 13G/A - Walgreens Boots Alliance, Inc. (0001618921) (Subject)
SC 13G/A - Walgreens Boots Alliance, Inc. (0001618921) (Subject)
SC 13G/A - Walgreens Boots Alliance, Inc. (0001618921) (Subject)
SC 13D/A - Walgreens Boots Alliance, Inc. (0001618921) (Filed by)
SC 13D/A - Walgreens Boots Alliance, Inc. (0001618921) (Filed by)
SC 13D/A - Walgreens Boots Alliance, Inc. (0001618921) (Filed by)
SC 13D/A - Walgreens Boots Alliance, Inc. (0001618921) (Filed by)
N-PX - Walgreens Boots Alliance, Inc. (0001618921) (Filer)
13F-HR - Walgreens Boots Alliance, Inc. (0001618921) (Filer)
8-K - Walgreens Boots Alliance, Inc. (0001618921) (Filer)
424B5 - Walgreens Boots Alliance, Inc. (0001618921) (Filer)
FWP - Walgreens Boots Alliance, Inc. (0001618921) (Subject)
424B5 - Walgreens Boots Alliance, Inc. (0001618921) (Filer)
8-K - Walgreens Boots Alliance, Inc. (0001618921) (Filer)
144 - Walgreens Boots Alliance, Inc. (0001618921) (Reporting)
8-K - Walgreens Boots Alliance, Inc. (0001618921) (Filer)
8-K - Walgreens Boots Alliance, Inc. (0001618921) (Filer)
Walgreens Boots Alliance, Inc. (NASDAQ:WBA) will release its fourth quarter and 2024 fiscal year-end results at 7 a.m. ET on Tuesday, October 15, 2024, followed by a one-hour conference call with WBA management beginning at 8:30 a.m. ET. The conference call will be simulcast through the WBA investor relations website at: http://investor.walgreensbootsalliance.com. A replay will be archived on the website for 12 months after the call. About Walgreens Boots Alliance Walgreens Boots Alliance (NASDAQ:WBA) is an integrated healthcare, pharmacy and retail leader serving millions of customers and patients every day, with a 170-year heritage of caring for communities. A trusted, global innovato
Walgreens Boots Alliance, Inc. (NASDAQ:WBA) today announced that its board of directors has declared a quarterly dividend of 25 cents per share, unchanged from the previous quarter. The dividend is payable on Sept. 12, 2024, to stockholders of record as of Aug. 21, 2024. Walgreens Boots Alliance and its predecessor company, Walgreen Co., have paid a dividend in 367 straight quarters (91 years). About Walgreens Boots Alliance Walgreens Boots Alliance (NASDAQ:WBA) is an integrated healthcare, pharmacy and retail leader serving millions of customers and patients every day, with a 170-year heritage of caring for communities. A trusted, global innovator in retail pharmacy with approximatel
Lowering Guidance in Continued Challenging Environment; Provides Strategic Update Third quarter financial highlights Third quarter earnings per share (EPS)* was $0.40 compared to earnings per share of $0.14 in the year-ago quarter which included a non-cash impairment of pharmacy license intangible assets in Boots UK Adjusted EPS** was $0.63, down 36.6 percent on a constant currency basis compared to the year-ago quarter, including a $0.24 impact from lower sale-leaseback gains, a challenging U.S. retail environment, and recent pharmacy industry trends Third quarter sales increased 2.6 percent year-over-year to $36.4 billion, up 2.5 percent on a constant currency basis Fiscal
Walgreens Boots Alliance, Inc. (NASDAQ:WBA) will release its fiscal 2024 third quarter results at 7 a.m. ET on Thursday, June 27, 2024, followed by a one-hour conference call with WBA management beginning at 8:30 a.m. ET. The conference call will be simulcast through the WBA investor relations website at: http://investor.walgreensbootsalliance.com. A replay will be archived on the website for 12 months after the call. About Walgreens Boots Alliance Walgreens Boots Alliance (NASDAQ:WBA) is an integrated healthcare, pharmacy and retail leader serving millions of customers and patients every day, with a 170-year heritage of caring for communities. A trusted, global innovator in retail
Walgreens Boots Alliance, Inc. (NASDAQ:WBA) today announced that its board of directors has declared a quarterly dividend of 25 cents per share, unchanged from the previous quarter. The dividend is payable on June 12, 2024, to stockholders of record as of May 21, 2024. Walgreens Boots Alliance and its predecessor company, Walgreen Co., have paid a dividend in 366 straight quarters (91 years). About Walgreens Boots Alliance Walgreens Boots Alliance (NASDAQ:WBA) is an integrated healthcare, pharmacy and retail leader serving millions of customers and patients every day, with a 170-year heritage of caring for communities. A trusted, global innovator in retail pharmacy with approximatel
Second quarter operational results in line with expectations, U.S. Healthcare achieved adjusted EBITDA profitability, narrowing full-year adjusted EPS guidance range Second quarter financial highlights Second quarter loss per share* was $6.85 compared to earnings per share of $0.81 in the year-ago quarter; Second quarter results included a $5.8 billion after-tax non-cash impairment charge related to VillageMD goodwill Adjusted earnings per share (EPS)** increased 3.4 percent to $1.20, up 2.8 percent on a constant currency basis reflecting lower adjusted effective tax rate** and improved profitability in U.S. Healthcare Second quarter sales increased 6.3 percent year-over-year to
Walgreens Boots Alliance, Inc. (NASDAQ:WBA) will release its fiscal 2024 second quarter results at 7 a.m. ET on Thursday, March 28, 2024, followed by a one-hour conference call with WBA management beginning at 8:30 a.m. ET. The conference call will be simulcast through the WBA investor relations website at: http://investor.walgreensbootsalliance.com. A replay will be archived on the website for 12 months after the call. About Walgreens Boots Alliance Walgreens Boots Alliance (NASDAQ:WBA) is an integrated healthcare, pharmacy and retail leader serving millions of customers and patients every day, with a 170-year heritage of caring for communities. A trusted, global innovator in retai
Walgreens Boots Alliance, Inc. (NASDAQ:WBA) today announced that its board of directors has declared a quarterly dividend of 25 cents per share, a reduction of 48 percent from the previous quarter. The dividend is payable on March 12, 2024, to stockholders of record as of Feb. 20, 2024. Chief Executive Officer Tim Wentworth said: "Since the start of my tenure with WBA, we have been evaluating our options across our strategies and operations, including those related to our capital allocation. We have made the difficult decision to reduce our quarterly dividend payment to 25 cents per share, to strengthen our long-term balance sheet and cash position. This action reinforces our goal of in
Results In Line with Expectations; Executing in a Challenging Environment First quarter and recent financial highlights First quarter loss per share* was $0.08 compared to a loss per share of $4.31 in the year-ago quarter; first quarter results included $278 million after-tax charge for fair value adjustments on variable prepaid forward derivatives related to the monetization of Cencora shares Adjusted earnings per share (EPS**) decreased 43.1 percent to $0.66, down 43.7 percent on a constant currency basis reflecting challenging retail market trends in the U.S. and a 21 percentage point headwind from a higher tax rate First quarter sales increased 10.0 percent year-over-year to
Walgreens Boots Alliance, Inc. (NASDAQ:WBA) will release its fiscal 2024 first quarter results at 7 a.m. ET on Thursday, January 4, 2024, followed by a one-hour conference call with WBA management beginning at 8:30 a.m. ET. The conference call will be simulcast through the WBA investor relations website at: http://investor.walgreensbootsalliance.com. A replay will be archived on the website for 12 months after the call. The replay will also be available from approximately 11:30 a.m. ET, Jan. 4, 2024 through Jan. 11, 2024, by calling + 1 800 770 2030 within the U.S. and Canada, or + 1 647 362 9199 internationally, using replay code 8277955. About Walgreens Boots Alliance Walgreens Bo
Leerink Partners initiated coverage of Walgreens Boots Alliance with a rating of Market Perform and set a new price target of $23.00
HSBC Securities downgraded Walgreens Boots Alliance from Hold to Reduce
Barclays initiated coverage of Walgreens Boots Alliance with a rating of Underweight and set a new price target of $21.00
HSBC Securities initiated coverage of Walgreens Boots Alliance with a rating of Hold and set a new price target of $27.00
JP Morgan upgraded Walgreens Boots Alliance from Neutral to Overweight and set a new price target of $30.00 from $27.00 previously
Morgan Stanley reiterated coverage of Walgreens Boots Alliance with a rating of Underweight and set a new price target of $27.00 from $37.00 previously
Deutsche Bank downgraded Walgreens Boots Alliance from Buy to Hold and set a new price target of $34.00 from $46.00 previously
Loop Capital initiated coverage of Walgreens Boots Alliance with a rating of Buy and set a new price target of $45.00
Morgan Stanley resumed coverage of Walgreens Boots Alliance with a rating of Underweight and set a new price target of $39.00
Cowen upgraded Walgreens Boots Alliance from Market Perform to Outperform and set a new price target of $54.00 from $43.00 previously
Names Tracey Koller as Chief Merchandising Officer and Sharmila Sudhakar as Group Vice President and Head of Digital Commerce Walgreens, the leading independent retail pharmacy and healthcare provider, today announced two key leadership appointments: Tracey Koller, senior vice president and chief merchandising officer, and Sharmila Sudhakar, group vice president and head of Walgreens digital commerce. The company believes these new appointments will significantly contribute to its efforts with regard to the turnaround of the business as the company focuses on enhancing the front of store and omnichannel experience for its customers while driving in-store efficiencies. This press release
NEW YORK, July 12, 2024 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) today announced that Super Micro Computer Inc. (NASDAQ:SMCI), will become a component of the Nasdaq-100 Index® (NASDAQ:NDX) and the Nasdaq-100 Equal Weighted™ Index (NASDAQ:NDXE) prior to market open on Monday, July 22, 2024. Super Micro Computer Inc. will replace Walgreens Boots Alliance Inc. (NASDAQ:WBA) in the Nasdaq-100 Index® and the Nasdaq-100 Equal Weighted Index. Walgreens Boots Alliance Inc. will also be removed from the Nasdaq-100 Ex-Tech Sector™ Index (NASDAQ:NDXX), the Nasdaq-100 ESG™ Index (NASDAQ:NDXESG), and the Nasdaq-100 Sustainable ESG Select™ Index (NASDAQ:NDXSES) on the same date. Super Micro Computer Inc
Dr. Shrank brings extensive healthcare experience, business leadership and clinical expertise to WBA board as the company undergoes strategic turnaround Walgreens Boots Alliance, Inc. (NASDAQ:WBA) today announced the appointment of William H. Shrank, M.D., to the company's board of directors. Dr. Shrank is globally recognized for his leadership and expertise in healthcare strategy, policy and population health. He joins the WBA board at an important time as the company strengthens its business. Currently, Dr. Shrank is a venture partner with the Bio + Health Team of Andreesen Horowitz, a private venture capital firm, a role he has held since January 2023. He previously served in a numbe
CHICAGO, April 15, 2024 (GLOBE NEWSWIRE) -- Beginning April 15th, Walgreens, a pharmacy and retail leader who plays a critical role in the U.S. healthcare system by providing a wide range of pharmacy and healthcare services, including those that drive equitable access to care for the nation's medically underserved populations, and Foundation for Sarcoidosis Research (FSR), the leading international sarcoidosis organization, are proud to announce its renewed partnership to raise education and awareness about sarcoidosis and the importance of spring vaccinations with all Alabama-based Walgreens stores. As part of April's Sarcoidosis Awareness Month from now through April 30th, all Walgree
Eligible Medicare Advantage members can now use their benefits to purchase approximately 1,700 items digitally for shipping, pickup or same-day delivery Today, Walgreens announced it is the first community pharmacy to accept a broad array of Medicare Advantage supplemental benefits online, through Walgreens.com and the Walgreens app. Eligible members can now shop from a catalog of approximately 1,700 Shop Eligible Products on Walgreens digital channels. Consumers have been able to shop using their Medicare Advantage supplemental benefits in stores since 2019 and this brings even greater convenience with new digital shopping solutions regardless of payment method. This press release featu
Appointment completes CEO Tim Wentworth's Executive Committee Walgreens Boots Alliance, Inc. (NASDAQ:WBA) today named Lanesha Minnix the company's executive vice president (EVP) and global chief legal officer. Minnix, most recently EVP, general counsel and corporate secretary for Ecolab, Inc., will assume her new role with WBA on April 15. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240226589815/en/Lanesha Minnix named global chief legal officer, Walgreens Boots Alliance (Photo: Business Wire) Minnix, who will report to WBA CEO Tim Wentworth and serve on his Executive Committee, will oversee the company's global legal, comp
NEW YORK, Feb. 20, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the Dow Jones Industrial Average (DJIA) and Dow Jones Transportation Average (DJTA) effective prior to the open of trading on Monday, February 26: Amazon.com Inc. (NASD:AMZN) will replace Walgreens Boots Alliance Inc. (NASD:WBA) in the Dow Jones Industrial Average. Reflecting the evolving nature of the American economy, this change will increase consumer retail exposure as well as other business areas in the DJIA. The index change was prompted by DJIA constituent Walmart Inc.'s (NYSE:WMT) decision to split its stock 3:1, which will reduce Walmart's index weight due to the price weighted construc
Brings deep healthcare and extensive finance experience Walgreens Boots Alliance, Inc. (NASDAQ:WBA) today announced the election of Robert L. (Robbie) Huffines to the company's board of directors at its 2024 Annual Meeting of Stockholders. He joins the board as an independent director and will serve on the board's Finance and Technology Committee. Huffines currently serves as Global Chairman of Investment Banking at J.P. Morgan Chase & Co., where he has guided healthcare companies for more than 30 years on strategy, mergers and acquisitions, divestitures and financing. He expects to retire from J.P. Morgan Chase early this year. Huffines brings experience across many healthcare vertic
Take five minutes with Walgreens this holiday season to explore trending, budget-friendly gifts and essentials Walgreens has everything you need to keep things merry and bright – with convenient in-person and online shopping options to save the day, especially when you need help last-minute. According to a new Walgreens U.S. gift giving trend survey, 83% of Americans found themselves getting a gift for someone at the very last minute—a trend even more common among Gen Z (90%) and parents (92%). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231213156937/en/Take five minutes with Walgreens this holiday season. (Photo: Business
Mr. Wentworth brings nearly three decades of healthcare leadership experience to WBA Walgreens Boots Alliance, Inc. (NASDAQ:WBA) today announced the appointment of Tim Wentworth as the company's new Chief Executive Officer, effective on October 23. Mr. Wentworth will also join the WBA Board of Directors upon assuming the role. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231011544834/en/Tim Wentworth named Walgreens Boots Alliance CEO (Photo: Business Wire) Most recently, as founding CEO of Evernorth, Cigna's health services organization that partners with health plans, employers and government organizations, Mr. Wentworth b
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Goldman Sachs cut the price target for SunPower Corporation (NASDAQ:SPWR) from $2 to $0.5. Goldman Sachs analyst Brian Lee maintained a Sell rating. SunPower shares gained 5.4% to close at $0.7158 on Monday. See how other analysts view this stock. Piper Sandler increased the price target for Cathay General Bancorp (NASDAQ:CATY) from $32 to $36. Piper Sandler analyst Matthew Clark maintained an Underweight rating. Cathay General Bancorp shares gained 2.4% to close at $43.02 on Monday. See how other
Analysts' ratings for Walgreens Boots Alliance (NASDAQ:WBA) over the last quarter vary from bullish to bearish, as provided by 14 analysts. In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 1 6 6 0 Last 30D 0 0 0 1 0 1M Ago 1 1 5 4 0 2M Ago 0 0 1 1 0 3M Ago 0 0 0 0 0 Analysts have recently evaluated Walgreens Boots Alliance and provided 12-month price targets. The average target is $13.86, accompanied by a high estimate of $22.00 and a low estimate of $7.00. A decline of 30.46% fro
Barclays analyst Steve Valiquette maintains Walgreens Boots Alliance (NASDAQ:WBA) with a Underweight and lowers the price target from $11 to $7.
Super Micro Computer Inc (NASDAQ:SMCI) shares are trading higher Monday after Friday’s announcement that the artificial intelligence server company will become a component of the Nasdaq-100 Equal Weighted Index. Last Friday, Nasdaq said Super Micro will join the Nasdaq-100 Index (NDX) and the Nasdaq-100 Equal Weighted Index (NDXE) before the market opens on Monday, July 22, 2024. In both indices, Super Micro will replace Walgreens Boots Alliance Inc (NASDAQ:WBA). Also Read: Super Micro Computer Stock Soars as AI Server Demand Boosts Market Confidence Super Micro stock also got a boost from Wall Street expecting leading contract chipmaker Taiwan Semiconductor Manufacturing Co (NYSE:T
The Federal Trade Commission is preparing to sue the largest three pharmacy-benefit managers over their tactics for negotiating prices for drugs including insulin, after a two-year investigation into whether the companies steer patients away from less-expensive medicines.https://www.wsj.com/health/pharma/ftc-to-sue-drug-managers-over-insulin-prices-b46af71f?mod=latest_headlines
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Truist Securities raised the price target for Belden Inc. (NYSE:BDC) from $119 to $123. Truist Securities analyst William Stein maintained a Buy rating. Belden shares rose 0.5% to close at $92.30 on Wednesday. See how other analysts view this stock. Baird boosted the price target for Quest Diagnostics Incorporated (NYSE:DGX) from $145 to $153. Baird analyst Eric Coldwell maintained a Neutral rating. Quest Diagnostics shares gained 3.1% to close at $140.90 on Wednesday. See how other analysts view t
Bitcoin (CRYPTO: BTC) analyst Ali Martinez has recently shared insights on the current state of the cryptocurrency market, suggesting that the recent price action could continue. What Happened: Martinez, who is known for his analysis of on-chain and technical indicators, took to X to share his observations. Despite the recent market turbulence, Martinez pointed out that only $280.9 million in longs and $25.4 million in shorts have been liquidated. He noted that previous mass liquidation events have seen over $1 billion wiped out. “This tells us either the $BTC dip is not over yet or shorts are about to get obliterated,” Martinez wrote. #Bitcoin price action has been brutal, but on
Whales with a lot of money to spend have taken a noticeably bearish stance on Walgreens Boots Alliance. Looking at options history for Walgreens Boots Alliance (NASDAQ:WBA) we detected 41 trades. If we consider the specifics of each trade, it is accurate to state that 36% of the investors opened trades with bullish expectations and 58% with bearish. From the overall spotted trades, 12 are puts, for a total amount of $712,593 and 29, calls, for a total amount of $1,375,488. Predicted Price Range Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $5.0 to $25.0 for Walgreens Boots Alliance over the recent three months. Anal